Allison Kurian and her colleagues found that more women with breast cancer are getting genetic tests that can detect multiple cancer-associated mutations rather than being tested only for mutations in the BRCA1 and BRCA2 genes.
Steve Fisch
Allison Kurian and her colleagues found that more women with breast cancer are getting genetic tests that can detect multiple cancer-associated mutations rather than being tested only for mutations in the BRCA1 and BRCA2 genes.
Steve Fisch